DPA Should NOT Be Included in Omega-3 Index Assessment
When evaluating a patient's omega-3 index, do not adjust or include docosapentaenoic acid (DPA) levels—the omega-3 index should remain exclusively EPA + DHA as currently defined. 1
The Evidence Against Including DPA
The omega-3 index was specifically designed and validated as the sum of EPA and DHA only, expressed as a percentage of total erythrocyte fatty acids. Research directly addressing this question found that:
- Erythrocyte DPA did not predict risk for total mortality, sudden cardiac death, or other cardiovascular events 1
- Most critically, DPA did not improve prediction of these outcomes when included alongside EPA and DHA 1
- Current scientific evidence does not support modifying the established omega-3 index formula 1
Why This Matters Clinically
The omega-3 index targets are well-established based on EPA + DHA alone:
- Desirable ("green zone"): >8%
- Intermediate ("yellow zone"): 4-8%
- Undesirable ("red zone"): <4% 2
These thresholds were derived from cardiovascular outcome data using EPA + DHA exclusively. Adding DPA would invalidate these evidence-based cutoffs and create confusion in clinical interpretation.
What About DPA's Biological Activity?
While DPA does have biological functions—including conversion to specialized pro-resolving mediators and potential anti-inflammatory effects 3—this does not justify its inclusion in the omega-3 index. The index serves as a prognostic biomarker for cardiovascular risk, not a comprehensive measure of all omega-3 fatty acid biology. DPA's half-life (6.4 days) and turnover characteristics differ from EPA (3.4 days) and DHA (6.3 days) 4, further supporting separate consideration.
Practical Clinical Approach
When reviewing omega-3 testing results:
- Calculate omega-3 index using EPA + DHA only
- Target supplementation to achieve >8% if below this threshold
- Use 250-1000 mg EPA + DHA daily depending on baseline status and indication 5, 2
- Note DPA levels separately if reported, but do not incorporate into the index calculation
Common Pitfall to Avoid
Some commercial laboratories may report "total omega-3" values that include DPA, ALA, or other omega-3 fatty acids. This is not the validated omega-3 index. Always verify that the reported index uses only EPA + DHA in the numerator 1.
The omega-3 index remains a standardized, evidence-based metric precisely because it maintains its original EPA + DHA-only definition, allowing for consistent interpretation across studies and clinical settings.